307 related articles for article (PubMed ID: 9703491)
1. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.
Karagas MR; Tosteson TD; Blum J; Morris JS; Baron JA; Klaue B
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1047-50. PubMed ID: 9703491
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
Karagas MR; Stukel TA; Tosteson TD
Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.
Karagas MR; Stukel TA; Morris JS; Tosteson TD; Weiss JE; Spencer SK; Greenberg ER
Am J Epidemiol; 2001 Mar; 153(6):559-65. PubMed ID: 11257063
[TBL] [Abstract][Full Text] [Related]
4. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
Karagas MR; Tosteson TD; Morris JS; Demidenko E; Mott LA; Heaney J; Schned A
Cancer Causes Control; 2004 Jun; 15(5):465-72. PubMed ID: 15286466
[TBL] [Abstract][Full Text] [Related]
5. Relationship between arsenic-containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan.
Cheng PS; Weng SF; Chiang CH; Lai FJ
J Dermatol; 2016 Feb; 43(2):181-6. PubMed ID: 26283637
[TBL] [Abstract][Full Text] [Related]
6. Toenail samples as an indicator of drinking water arsenic exposure.
Karagas MR; Morris JS; Weiss JE; Spate V; Baskett C; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):849-52. PubMed ID: 8896897
[TBL] [Abstract][Full Text] [Related]
7. Markers of low level arsenic exposure for evaluating human cancer risks in a US population.
Karagas MR; Le CX; Morris S; Blum J; Lu X; Spate V; Carey M; Stannard V; Klaue B; Tosteson TD
Int J Occup Med Environ Health; 2001; 14(2):171-5. PubMed ID: 11548067
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA.
Slotnick MJ; Meliker JR; Nriagu JO
J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735
[TBL] [Abstract][Full Text] [Related]
9. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
Chiou HY; Chiou ST; Hsu YH; Chou YL; Tseng CH; Wei ML; Chen CJ
Am J Epidemiol; 2001 Mar; 153(5):411-8. PubMed ID: 11226969
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire.
Applebaum KM; Karagas MR; Hunter DJ; Catalano PJ; Byler SH; Morris S; Nelson HH
Environ Health Perspect; 2007 Aug; 115(8):1231-6. PubMed ID: 17687452
[TBL] [Abstract][Full Text] [Related]
11. Diet and toenail arsenic concentrations in a New Hampshire population with arsenic-containing water.
Cottingham KL; Karimi R; Gruber JF; Zens MS; Sayarath V; Folt CL; Punshon T; Morris JS; Karagas MR
Nutr J; 2013 Nov; 12():149. PubMed ID: 24237880
[TBL] [Abstract][Full Text] [Related]
12. Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.
Baris D; Waddell R; Beane Freeman LE; Schwenn M; Colt JS; Ayotte JD; Ward MH; Nuckols J; Schned A; Jackson B; Clerkin C; Rothman N; Moore LE; Taylor A; Robinson G; Hosain GM; Armenti KR; McCoy R; Samanic C; Hoover RN; Fraumeni JF; Johnson A; Karagas MR; Silverman DT
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27140955
[TBL] [Abstract][Full Text] [Related]
13. Estimating water supply arsenic levels in the New England Bladder Cancer Study.
Nuckols JR; Freeman LE; Lubin JH; Airola MS; Baris D; Ayotte JD; Taylor A; Paulu C; Karagas MR; Colt J; Ward MH; Huang AT; Bress W; Cherala S; Silverman DT; Cantor KP
Environ Health Perspect; 2011 Sep; 119(9):1279-85. PubMed ID: 21421449
[TBL] [Abstract][Full Text] [Related]
14. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley.
Knobeloch LM; Zierold KM; Anderson HA
J Health Popul Nutr; 2006 Jun; 24(2):206-13. PubMed ID: 17195561
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group.
Lichter MD; Karagas MR; Mott LA; Spencer SK; Stukel TA; Greenberg ER
Arch Dermatol; 2000 Aug; 136(8):1007-11. PubMed ID: 10926736
[TBL] [Abstract][Full Text] [Related]
16. Arsenic and skin cancer in the USA: the current evidence regarding arsenic-contaminated drinking water.
Mayer JE; Goldman RH
Int J Dermatol; 2016 Nov; 55(11):e585-e591. PubMed ID: 27420023
[TBL] [Abstract][Full Text] [Related]
17. Sampling private wells at past homes to estimate arsenic exposure: a methodologic study in New England.
Colt JS; Baris D; Clark SF; Ayotte JD; Ward M; Nuckols JR; Cantor KP; Silverman DT; Karagas M
J Expo Anal Environ Epidemiol; 2002 Sep; 12(5):329-34. PubMed ID: 12198581
[TBL] [Abstract][Full Text] [Related]
18. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
[TBL] [Abstract][Full Text] [Related]
19. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer in a U.S. population with low to moderate arsenic exposure.
Heck JE; Andrew AS; Onega T; Rigas JR; Jackson BP; Karagas MR; Duell EJ
Environ Health Perspect; 2009 Nov; 117(11):1718-23. PubMed ID: 20049123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
